TransCode Therapeutics, Inc. (RNAZ)
NASDAQ: RNAZ · Real-Time Price · USD
3.760
-0.060 (-1.57%)
At close: Dec 20, 2024, 4:00 PM
3.830
+0.070 (1.86%)
After-hours: Dec 20, 2024, 7:00 PM EST
TransCode Therapeutics Market Cap
TransCode Therapeutics has a market cap or net worth of $1.97 million as of December 20, 2024. Its market cap has decreased by -61.00% in one year.
Market Cap
1.97M
Enterprise Value
243.85K
1-Year Change
-61.00%
Ranking
Category
Stock Price
$3.76
Market Cap Chart
Since the IPO on July 9, 2021, TransCode Therapeutics's market cap has decreased from $47.87M to $1.97M, a decrease of -95.89%. That is a compound annual growth rate of -60.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 1.97M | -52.44% |
| Dec 29, 2023 | 4.14M | -52.59% |
| Dec 30, 2022 | 8.72M | -73.34% |
| Dec 31, 2021 | 32.72M | -31.64% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Dermata Therapeutics | 2.14M |
| Bluejay Diagnostics | 2.10M |
| Cyclacel Pharmaceuticals | 2.08M |
| cbdMD | 2.05M |
| Salarius Pharmaceuticals | 2.03M |
| Akanda | 1.94M |
| IMAC Holdings | 1.93M |
| Phio Pharmaceuticals | 1.84M |